Sangwon Lee

Title: Innovations of Sangwon Lee

Introduction

Sangwon Lee is an accomplished inventor based in Branford, CT, with a notable portfolio of patents. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide compositions and therapeutic antibodies.

Latest Patents

Sangwon Lee holds two patents that showcase his innovative work. The first patent is for "Mutant FGF21 polypeptide compositions," which relates to certain mutant FGF21 polypeptide constructs. This invention includes constructs that bind to β-Klotho more tightly than wild-type FGF21 and features mutations in specific residues. The second patent is for "Anti-ErbB antibodies and methods of use thereof," which involves antibodies that bind to ErbB, a receptor tyrosine kinase, and modulate its activity. This invention has potential applications in treating disorders such as cancer.

Career Highlights

Throughout his career, Sangwon Lee has worked with prestigious organizations, including Yale University and Celldex Therapeutics Limited. His work in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Sangwon Lee has collaborated with notable professionals in his field, including Joseph Schlessinger and Diego Alvarado. These collaborations have further enriched his research and innovation efforts.

Conclusion

Sangwon Lee's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in therapeutic applications and polypeptide research.